Abstract
Background
Currently, phenotypic resistance is a serious therapeutic challenge, and a definitive remedy has not been discovered yet. Biofilm formation and persister cells are two well-studied phenotypic resistance, leading to the recalcitrance and relapse of different chronic infections. It appears that the presence of persister cells in biofilm is the main factor in the relapse of infections and treatment failure. Thus, we aimed to evaluate the expression of biofilm-associated genes in persister and non-persister E. faecalis isolates.
Methods
Ninety-five clinical E. faecalis isolates were investigated using microtiter broth dilution (MBD) and microtiter plate (MTP) assay to determine the vancomycin-sensitive isolates and biofilm formation, respectively. To this end, 91 vancomycin-sensitive E. faecalis isolates (biofilm producers) were screened by PCR to determine the presence of biofilm-related genes (gelE, esp, and agg). The vancomycin-tolerant isolates were determined by MTP assay. Bacterial persister assay was performed using an enzymatic lysis assay. Finally, the expression of biofilm-related genes was evaluated in persisters and non-persister isolates of E. faecalis by real-time PCR assay.
Results
E. faecalis isolates indicated a high (95.8%) sensitivity to vancomycin. PCR assay identified gelE, esp, and agg genes in 91 (100%), 72(79.12), and 74(81.32) of isolates, respectively. All E. faecalis biofilm producers were tolerant to vancomycin, and minimum bactericidal concentration for biofilms (MBCB) was > 2500 µg/ml. Based on enzymatic lysis assay, among 91 isolates, only 3 persister were isolated. The increased expression level of biofilm-related genes was observed in persister than non-persister E. faecalis isolates.
Conclusion
The expression of biofilm-related genes is higher in persister than non-persister isolates of E. faecalis.